SCHEMBL25820605

SCHEMBL25820605

Cc1ccc(Nc2ccnc3ccc(C#N)cc23)cc1C(=O)Nc1cccc(Nc2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 1/20 0.51
DNMT1 P26358 7/20 0.49
DNMT3A Q9Y6K1 6/20 0.49
MAPKAPK2 P49137 2/20 0.49
DNMT3L Q9UJW3 4/20 0.47
GAK O14976 1/20 0.46
RIPK2 O43353 1/20 0.46
COQ8A Q8NI60 1/20 0.46
NLK Q9UBE8 1/20 0.46
BLK P51451 2/20 0.46
EGFR P00533 2/20 0.46
LRRK2 Q5S007 1/20 0.44
EHMT1 Q9H9B1 2/20 0.44
CCNC P24863 1/20 0.43
CDK8 P49336 1/20 0.43
HTT P42858 1/20 0.43
KDM4E B2RXH2 1/20 0.43
USP2 O75604 1/20 0.43
ALDH1A1 P00352 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25487269 0.95 BRAF (0.51) BRAFDNMT1DNMT3AMAPKAPK2DNMT3L
SCHEMBL25820620 0.89 DNMT1 (0.49) BRAFDNMT1DNMT3AMAPKAPK2DNMT3L
SCHEMBL24006176 0.89 USP2 (0.54) BRAFDNMT1DNMT3AMAPKAPK2DNMT3L
SCHEMBL24003789 0.88 DNMT1 (0.59) BRAFDNMT1DNMT3AMAPKAPK2DNMT3L
SCHEMBL24003754 0.88 USP2 (0.51) BRAFDNMT1DNMT3AMAPKAPK2DNMT3L
SCHEMBL25820606 0.88 DNMT1 (0.51) BRAFDNMT1DNMT3AMAPKAPK2DNMT3L
SCHEMBL25820613 0.87 DNMT1 (0.61) BRAFDNMT1DNMT3AMAPKAPK2DNMT3L
SCHEMBL25820602 0.87 DNMT1 (0.51) BRAFDNMT1DNMT3AMAPKAPK2DNMT3L
SCHEMBL25820641 0.86 DNMT1 (0.52) BRAFDNMT1DNMT3ADNMT3LBLK
SCHEMBL24010972 0.86 DNMT1 (0.64) BRAFDNMT1DNMT3AMAPKAPK2DNMT3L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA BRAF 154/4885DNMT1 4335/4885DNMT3A 4603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.